HEST Investments Leads $1.8 Million SPV Investment in Secretome Therapeutics to Advance Human Trials
The Funding Marks a Significant Step in Revolutionizing Regernative Medicine DALLAS, Sept. 17, 2024 /PRNewswire/ -- HEST Investments, a Dallas-based venture...